On this page:OverviewPublicationsResearchersInstitutionsOpen access
ScholarIQanswers from OpenAlex

Kallyope (United States)

InstitutionResearch output, impact & collaborations

Kallyope (United States) is a institution indexed in ScholarIQ from OpenAlex.

What is known about Kallyope (United States)?

ScholarIQrecord summary

Kallyope (United States) is a research organisation in New York, US. OpenAlex records 38 works and 1,884 citations for it. 51 researchers list it as their most recent affiliation.

How many works does Kallyope (United States) have?

ScholarIQindexed works

Kallyope (United States) has 38 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Kallyope (United States) have?

ScholarIQcitation count

Kallyope (United States) has 1,884 citations in the OpenAlex counts ScholarIQ stores.

How many researchers are at Kallyope (United States)?

ScholarIQresearcher count

Kallyope (United States) has 51 researchers in the ScholarIQ index.

What is the average h-index at Kallyope (United States)?

ScholarIQavg h-index

Kallyope (United States) has an average h-index of 42 in OpenAlex.

What is the ROR of Kallyope (United States)?

ScholarIQror

The ROR for Kallyope (United States) is on the source record.

What is the OpenAlex record for Kallyope (United States)?

ScholarIQopenalex

The OpenAlex for Kallyope (United States) is on the source record.

Who are the most-cited researchers behind Kallyope (United States)?

ScholarIQtop researchers by citations
1
Nancy A. Thornberry · Peptidase Inhibition and Analysis
151 works40,282 citations
2
Robert P. J. Barretto · Advanced Fluorescence Microscopy Techniques
17 works18,526 citations

What are the most-cited papers on Kallyope (United States)?

ScholarIQmost cited works
(2<i>R</i>)-4-Oxo-4-[3-(Trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-<i>a</i>]pyrazin- 7(8<i>H</i>)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine:  A Potent, Orally Active Dipeptidyl Peptidase IV Inhibitor for the Treatment of Type 2 Diabetes
Dooseop Kim, Liping Wang, Maria Beconi, George J. Eiermann, Michael H. Fisher, Huaibing He, Gerard J. Hickey, Jennifer E. Kowalchick, Barbara Leiting, Kathryn A. Lyons, Frank Marsilio, Margaret E. McCann, Reshma A. Patel, Aleksandr Petrov, Giovanna Scapin, Sangita B. Patel, Ranabir Sinha Roy, Joseph K. Wu, Matthew J. Wyvratt, Bei B. Zhang, Lan Zhu, Nancy A. Thornberry, Ann E. Weber
Journal of Medicinal Chemistry. 2004818 CitationsOPEN ACCESS
Dual Role of Caspase-11 in Mediating Activation of Caspase-1 and Caspase-3 under Pathological Conditions
Shin-Jung Kang, Suyue Wang, Hideaki Hara, Erin P. Peterson, Shobu Namura, Sepideh Amin‐Hanjani, Zhihong Huang, Anu Srinivasan, Kevin J. Tomaselli, Nancy A. Thornberry, Michael A. Moskowitz, Junying Yuan
The Journal of Cell Biology. 2000328 CitationsOPEN ACCESS
Dipeptidyl Peptidase-4 Inhibitors Administered in Combination With Metformin Result in an Additive Increase in the Plasma Concentration of Active GLP-1
Elizabeth Migoya, Raynald Bergeron, Jutta Miller, Rebekah Snyder, Michael Tanen, D Hilliard, Barry D. Weiss, Patrick Larson, Marie Gutierrez, Guoqiang Jiang, Fang Liu, Kelly Ann D. Pryor, Jun Yao, Lixia Zhu, Jens J. Holst, Carolyn F. Deacon, Gary Herman, Nancy A. Thornberry, John M. Amatruda, Debora Williams‐Herman, John A. Wagner, Ranabir SinhaRoy
Clinical Pharmacology & Therapeutics. 2010178 Citations

How much of the research on Kallyope (United States) is open access?

ScholarIQopen access share
67%OPEN ACCESS
Gold
0%
Green
33%
Hybrid
0%
Bronze
33%
Closed
33%

Related on ScholarIQ

470M+ articles · 14-day free trial